Our recent acquisition of contract research organization Yurogen Biosystems has allowed us to revamp our custom antibody service offerings. Through our partnership, we are excited to offer a new custom recombinant monoclonal antibody development service based on the proprietary SMAb™ technology.
The innovative single cell-based monoclonal antibody (SMAbTM) platform allows for the efficient production of recombinant antibodies with superior specificity, sensitivity, and application utility compared to traditional hybridoma platforms.
Take advantage of our limited-time, introductory offer: recombinant monoclonal antibodies for the price of hybridoma development.
Reproducibility & Consistency
- Recombinant technology allows for antibodies with long-term lot-to-lot consistency, ensuring highly reproducible results.
Diverse Application Utility
- Recombinant rabbit antibodies are suitable for a variety of applications, including: immunohistochemistry, immunofluorescence, flow cytometry, western blot and ELISA.
- Production at our international facility allows us to deliver our service at a low price, without sacrificing the quality of antibodies developed.